Sign in
4

Changes in Ownership

Sunshine Biopharma Inc. Filed Acc 0001128732-20-000003

Chief Executive Officer acquired 2,400,000 shares (grant or award)

  • Chief Executive Officer acquired 323,673 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Slilaty Steve N. Chief Executive Officer 2019-10-20 Grant or award +1,100,000 $0.00 $1,100 2,043,461 D: show line 1 in the form
Slilaty Steve N. Chief Executive Officer 2019-12-19 Grant or award +1,300,000 $0.00 $1,300 3,343,461 D: show line 2 in the form
Slilaty Steve N. Chief Executive Officer 2019-12-31 Other acquisition +323,673 $0.00 $324 861,209 I: show line 3 in the form
Loading xslF345X03/primary_doc.xml…